-
Published24/11/2018
-
Deadline20/12/2018
-
Opening of tenders20/12/2018
-
Awarded12/02/2019
-
Today18/11/2025
Utilities
United Kingdom-Runcorn: Pharmaceutical products
Invitation to offer for National Framework Agreement for the Supply of Generic Pharmaceuticals — Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz.
Offer reference number: CM/PHG/17/5545
Period of Framework Agreement: the total maximum duration of the Framework Agreement to be no more than 36 months.
Potential periods of call-offs under the Framework Agreement:
— North West London: 21.5.2019 to 31.10.2020 (18 months),
— North Central and East London: 21.5.2019 to 31.10.2020 (18 months),
— South East and West London: 21.5.2019 to 31.10.2020 (18 months),
— North of England: 21.5.2019 to 31.10.2020 (18 months),
— Midlands and East: 21.5.2019 to 31.10.2020 (18 months),
— South of England: 21.5.2019 to 31.10.2020 (18 months).
Official name: The NHS Commissioning Board (operating under the name of NHS England)
Postal address: 2nd Floor, Rutland House
Town: Runcorn
NUTS code: UK
Postal code: WA7 2ES
Country: GBR
Main address: https://nhsengland.bravosolution.co.uk
Electronic via:
https://nhsengland.bravosolution.co.uk
Framework agreement with several operators
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.